These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6119606)

  • 41. The neuroleptic malignant syndrome.
    Kimsey LR; Gibbs JT; Glen RS; Markette JR; Kosted E
    Tex Med; 1983 Oct; 79(10):54-5. PubMed ID: 6138871
    [No Abstract]   [Full Text] [Related]  

  • 42. [Malignant neuroleptic syndrome, a severe complication of neuroleptic therapy. Anatomo-clinical aspects].
    Stroia I; Alexianu M; Popa G; Rişca E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):307-11. PubMed ID: 6134328
    [No Abstract]   [Full Text] [Related]  

  • 43. General anesthesia after neuroleptic malignant syndrome.
    Lotstra F; Linkowski P; Mendlewicz J
    Biol Psychiatry; 1983 Feb; 18(2):243-7. PubMed ID: 6131703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
    Meltzer HY
    Psychopharmacologia; 1973; 29(4):337-46. PubMed ID: 4707025
    [No Abstract]   [Full Text] [Related]  

  • 45. Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug.
    Ossowska K; Konieczny J; Lorenc-Koci E; Schulze G; Coper H; Wolfarth S
    J Physiol Pharmacol; 1998 Jun; 49(2):311-7. PubMed ID: 9670114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clouding of consciousness on the withdrawal of caffeine and sodium benzoate].
    Akita I; Suwaki H; Ikeda H
    Arukoru Kenkyuto Yakubutsu Ison; 1988 Mar; 23(1):12-7. PubMed ID: 3408389
    [No Abstract]   [Full Text] [Related]  

  • 47. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
    de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
    Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
    [No Abstract]   [Full Text] [Related]  

  • 48. Neuroleptic malignant syndrome and serotonin syndrome.
    Nisijima K; Shioda K; Iwamura T
    Prog Brain Res; 2007; 162():81-104. PubMed ID: 17645916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic malignant syndrome.
    Cope RV
    Br J Psychiatry; 1983 Aug; 143():202-3. PubMed ID: 6137256
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuroleptic malignant syndrome.
    Morris HH; McCormick WF; Reinarz JA
    Arch Neurol; 1980 Jul; 37(7):462-3. PubMed ID: 7387498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD
    Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hyperthermia with acute rhabdomyolysis in a psychotic treated with neuroleptics].
    Reis J; Felten P; Rumbach L; Collard M
    Rev Neurol (Paris); 1983; 139(10):595-6. PubMed ID: 6139869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible malignant neuroleptic syndrome that associated with hypothyroidism.
    Taskapan C; Sahin I; Taskapan H; Kaya B; Kosar F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):745-8. PubMed ID: 15927337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroleptic malignant syndrome: response to dantrolene sodium.
    May DC; Morris SW; Stewart RM; Fenton BJ; Gaffney FA
    Ann Intern Med; 1983 Feb; 98(2):183-4. PubMed ID: 6824251
    [No Abstract]   [Full Text] [Related]  

  • 56. "Syndrome malin"-like symptoms probably due to interaction between neuroleptica and oral antidiabetic agents.
    Yamada M; Ishimaru T
    Folia Psychiatr Neurol Jpn; 1978; 32(1):33-40. PubMed ID: 658848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroleptic malignant syndrome and malignant hyperthermia.
    Caroff S; Rosenberg H; Gerber JC
    J Clin Psychopharmacol; 1983 Apr; 3(2):120-1. PubMed ID: 6132930
    [No Abstract]   [Full Text] [Related]  

  • 58. [A case of consciousness disturbance and polyneuropathy after exposure to paraquat and its nerve biopsy findings].
    Uchihara T; Kanda T; Yamada M; Yoshihara M; Tsukagoshi H; Watabiki S; Ishiai S
    Rinsho Shinkeigaku; 1986 Mar; 26(3):237-40. PubMed ID: 3015471
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroleptic malignant syndrome.
    Bates I; Courtenay-Evans RJ
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1913. PubMed ID: 6428599
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug-induced hyperthermia and muscle rigidity: a practical approach.
    Hadad E; Weinbroum AA; Ben-Abraham R
    Eur J Emerg Med; 2003 Jun; 10(2):149-54. PubMed ID: 12789076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.